Overview

A Study to Evaluate the Effect of IV Doses of Rivipansel on Subjects With Renal Impairment and in Healthy Subjects

Status:
Completed
Trial end date:
2018-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effect of renal impairment on rivipansel.
Phase:
Phase 1
Details
Lead Sponsor:
GlycoMimetics Incorporated
Pfizer